Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

New compounds with carborane showed anti-androgen effects similar to flutamide.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Inhibiting certain enzymes made female rats more sensitive to low-level pain.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Finasteride boosts morphine's pain relief and prevents tolerance and withdrawal in rats.

Researchers made two new compounds that could be used for medicine.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

SARMs work differently in tissues due to unique interactions and structures.

Certain alkaloids could help create new coronavirus drugs.

Asiasari radix extract may relieve certain types of pain by affecting GABA and NMDA receptors.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.